US5929549A
(en)
*
|
1998-04-02 |
1999-07-27 |
Pacific Scientific Company |
Fault tolerant electric machine
|
US6437529B1
(en)
*
|
1998-05-04 |
2002-08-20 |
Comair Rotron, Inc. |
Multi-stator motor with independent stator circuits
|
DE19856647B4
(de)
*
|
1998-12-09 |
2007-03-01 |
Canders, Wolf-R., Prof. Dr.-Ing. |
Elektrischer Hochmomentmotor
|
DE60231675D1
(de)
*
|
2001-06-01 |
2009-05-07 |
Ihi Aerospace Co Ltd |
Elektromotorischer Stellantrieb und Verfahren zum Steuern desselben
|
EP1296443B1
(de)
*
|
2001-09-19 |
2006-10-04 |
Parker Hannifin Corporation |
Motorantrieb und System
|
US6819017B2
(en)
|
2002-01-02 |
2004-11-16 |
Intel Corporation |
Method and apparatus for fan redundancy
|
US6700266B2
(en)
*
|
2002-01-02 |
2004-03-02 |
Intel Corporation |
Multiple fault redundant motor
|
US6724183B2
(en)
|
2002-01-02 |
2004-04-20 |
Intel Corporation |
Method and apparatus for detecting bearing failure
|
US6791209B2
(en)
|
2002-01-02 |
2004-09-14 |
Intel Corporation |
Power and control for power supply fans
|
EP2505648A1
(de)
|
2006-05-05 |
2012-10-03 |
Isis Pharmaceuticals, Inc. |
Verbindungen und Verfahren zur Modulation der Expression von PTP1B
|
CA3044969A1
(en)
|
2006-05-05 |
2007-12-21 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulating gene expression
|
US7443642B2
(en)
|
2006-05-26 |
2008-10-28 |
Pratt & Whitney Canada Corp. |
Electric motor control
|
GB0613941D0
(en)
|
2006-07-13 |
2006-08-23 |
Pml Flightlink Ltd |
Electronically controlled motors
|
CA2667055C
(en)
|
2006-10-18 |
2017-05-09 |
Isis Pharmaceuticals, Inc. |
Antisense compounds
|
US7605503B2
(en)
|
2007-03-28 |
2009-10-20 |
General Electric Company |
Fault-tolerant permanent magnet machine with reconfigurable stator core slot opening and back iron flux paths
|
US7541705B2
(en)
|
2007-03-28 |
2009-06-02 |
General Electric Company |
Fault-tolerant permanent magnet machine with reconfigurable flux paths in stator back iron
|
US7605504B2
(en)
|
2007-03-28 |
2009-10-20 |
General Electric Company |
Fault-tolerant permanent magnet machine with reconfigurable stator core slot flux paths
|
DE102007048642A1
(de)
*
|
2007-10-10 |
2009-04-16 |
Mtu Aero Engines Gmbh |
Elektrischer Antrieb, insbesondere für eine Kraftstoffzumesseinheit für ein Flugzeugtriebwerk
|
US7786684B2
(en)
*
|
2007-10-22 |
2010-08-31 |
Honeywell International Inc. |
Electromechanical flight control system and method for rotorcraft
|
EP2297322A1
(de)
|
2008-06-04 |
2011-03-23 |
The Board of Regents of The University of Texas System |
Modulation der genexpression über das abzielen kleiner endogener rna auf genpromotoren
|
WO2010014592A1
(en)
|
2008-07-29 |
2010-02-04 |
The Board Of Regents Of The University Of Texas Sytem |
Selective inhibition of polyglutamine protein expression
|
US8987435B2
(en)
|
2008-10-24 |
2015-03-24 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and methods
|
US8476798B2
(en)
|
2008-11-28 |
2013-07-02 |
Pratt & Whitney Canada Corp. |
Tandem electric machine arrangement
|
US20120021515A1
(en)
|
2009-02-06 |
2012-01-26 |
Swayze Eric E |
Oligomeric compounds and methods
|
EP2421972A2
(de)
|
2009-04-24 |
2012-02-29 |
The Board of Regents of The University of Texas System |
Modulation der genexpression mit auf genregionen nach 3-untranslatierten regionen gerichteten oligomeren
|
GB2462940B8
(en)
*
|
2009-09-03 |
2012-03-28 |
Protean Holdings Corp |
Electric motor and electric generator.
|
US8749192B2
(en)
|
2009-09-03 |
2014-06-10 |
Protean Electric Limited |
Electric motor and electric generator
|
WO2011053994A1
(en)
|
2009-11-02 |
2011-05-05 |
Alnylam Pharmaceuticals, Inc. |
Modulation of ldl receptor gene expression with double-stranded rnas targeting the ldl receptor gene promoter
|
ES2677969T3
(es)
|
2010-01-08 |
2018-08-07 |
Ionis Pharmaceuticals, Inc. |
Modulación de la expresión tipo angiopoyetina 3
|
WO2011097388A1
(en)
|
2010-02-03 |
2011-08-11 |
Alnylam Pharmaceuticals, Inc. |
Selective inhibition of polyglutamine protein expression
|
EP2534262B1
(de)
|
2010-02-08 |
2016-12-14 |
Ionis Pharmaceuticals, Inc. |
Selektive reduktion von allelvarianten
|
ES2733708T3
(es)
|
2010-02-08 |
2019-12-02 |
Ionis Pharmaceuticals Inc |
Reducción selectiva de variantes alélicas
|
US8993738B2
(en)
|
2010-04-28 |
2015-03-31 |
Isis Pharmaceuticals, Inc. |
Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
|
WO2011139699A2
(en)
|
2010-04-28 |
2011-11-10 |
Isis Pharmaceuticals, Inc. |
5' modified nucleosides and oligomeric compounds prepared therefrom
|
WO2011139695A2
(en)
|
2010-04-28 |
2011-11-10 |
Isis Pharmaceuticals, Inc. |
Modified 5' diphosphate nucleosides and oligomeric compounds prepared therefrom
|
BR112012027547B1
(pt)
|
2010-04-29 |
2022-06-14 |
Ionis Pharmaceuticals, Inc |
Oligonucleotídeo modificado de fita simples, composição, e seus usos para tratar amiloidose transtirretina, reduzir os seus sintomas e para reduzir a expressão de mrna ou de proteína de transtirretina
|
WO2011139911A2
(en)
|
2010-04-29 |
2011-11-10 |
Isis Pharmaceuticals, Inc. |
Lipid formulated single stranded rna
|
WO2011156278A1
(en)
|
2010-06-07 |
2011-12-15 |
Isis Pharmaceuticals, Inc. |
Bicyclic nucleosides and oligomeric compounds prepared therefrom
|
US8846637B2
(en)
|
2010-06-08 |
2014-09-30 |
Isis Pharmaceuticals, Inc. |
Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
|
AU2011282217B2
(en)
|
2010-07-19 |
2015-12-03 |
Ionis Pharmaceuticals, Inc. |
Modulation of dystrophia myotonica-protein kinase (DMPK) expression
|
JP5577506B2
(ja)
|
2010-09-14 |
2014-08-27 |
ソーラテック コーポレイション |
遠心式ポンプ装置
|
FR2967310B1
(fr)
|
2010-11-04 |
2013-08-02 |
Xap |
Moteur electromagnetique sans balai
|
AU2011329777B2
(en)
|
2010-11-17 |
2016-06-09 |
Ionis Pharmaceuticals, Inc. |
Modulation of alpha synuclein expression
|
EP3467109A1
(de)
|
2011-02-08 |
2019-04-10 |
Ionis Pharmaceuticals, Inc. |
Oligomere verbindungen mit bicyclischen nukleotiden und verwendungen davon
|
WO2012132850A1
(ja)
|
2011-03-28 |
2012-10-04 |
Ntn株式会社 |
回転駆動装置およびそれを用いた遠心式ポンプ装置
|
JP5943993B2
(ja)
|
2011-04-01 |
2016-07-05 |
アイオーニス ファーマシューティカルズ, インコーポレーテッドIonis Pharmaceuticals,Inc. |
転写のシグナル伝達及び活性化因子3(stat3)発現の調節
|
DE102011016336A1
(de)
|
2011-04-07 |
2012-10-11 |
Airbus Operations Gmbh |
Hochauftriebssystem für ein Luftfahrzeug
|
CA2832972C
(en)
|
2011-04-13 |
2019-04-30 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of ptp1b expression
|
CN111172162A
(zh)
|
2011-04-21 |
2020-05-19 |
葛兰素史克公司 |
乙型肝炎病毒(hbv)表达的调节
|
CA2834232A1
(en)
|
2011-04-27 |
2012-11-01 |
Isis Pharmaceuticals, Inc. |
Modulation of apolipoprotein ciii (apociii) expression
|
WO2012170347A1
(en)
|
2011-06-09 |
2012-12-13 |
Isis Pharmaceuticals, Inc. |
Bicyclic nucleosides and oligomeric compounds prepared therefrom
|
US9315811B2
(en)
|
2011-06-10 |
2016-04-19 |
Ionis Pharmaceuticals, Inc. |
Methods for modulating kallikrein (KLKB1) expression
|
CN103597074A
(zh)
|
2011-06-16 |
2014-02-19 |
Isis制药公司 |
成纤维细胞生长因子受体4表达的反义调节
|
WO2013003808A1
(en)
|
2011-06-29 |
2013-01-03 |
Isis Pharmaceuticals, Inc. |
Methods for modulating kallikrein (klkb1) expression
|
US20150051389A1
(en)
|
2011-08-11 |
2015-02-19 |
Isis Pharmaceuticals, Inc. |
Selective antisense compounds and uses thereof
|
WO2013033230A1
(en)
|
2011-08-29 |
2013-03-07 |
Isis Pharmaceuticals, Inc. |
Oligomer-conjugate complexes and their use
|
EP2758533B1
(de)
|
2011-09-20 |
2018-04-11 |
Ionis Pharmaceuticals, Inc. |
Antisense-modulation der gcgr-expression
|
CA2853373A1
(en)
|
2011-10-25 |
2013-05-02 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of gccr expression
|
EP2776564B1
(de)
|
2011-11-07 |
2019-10-02 |
Ionis Pharmaceuticals, Inc. |
Modulation der tmprss6 expression
|
ES2673960T3
(es)
|
2011-12-22 |
2018-06-26 |
Ionis Pharmaceuticals, Inc. |
Métodos para modular la expresión de un transcrito-1 de adenocarcinoma en pulmón asociado a metástasis (MALAT-1)
|
US20150025231A1
(en)
|
2012-01-11 |
2015-01-22 |
Cold Spring Harbor Laboratory |
Compositions and methods for modulation of ikbkap splicing
|
WO2013120003A1
(en)
|
2012-02-08 |
2013-08-15 |
Isis Pharmaceuticals, Inc. |
Modulation of rna by repeat targeting
|
US8837096B2
(en)
|
2012-03-13 |
2014-09-16 |
Thoratec Corporation |
Fault monitor for fault tolerant implantable pump
|
US9221864B2
(en)
|
2012-04-09 |
2015-12-29 |
Isis Pharmaceuticals, Inc. |
Tricyclic nucleic acid analogs
|
WO2013154799A1
(en)
|
2012-04-09 |
2013-10-17 |
Isis Pharmaceuticals, Inc. |
Tricyclic nucleosides and oligomeric compounds prepared therefrom
|
EP3336189A1
(de)
|
2012-04-20 |
2018-06-20 |
Ionis Pharmaceuticals, Inc. |
Oligomere verbindungen mit bicyclischen nukleotiden und verwendungen davon
|
WO2013177248A2
(en)
|
2012-05-22 |
2013-11-28 |
Isis Pharmaceuticals, Inc. |
Modulation of enhancer rna mediated gene expression
|
RU2624028C2
(ru)
|
2012-05-24 |
2017-06-30 |
Ионис Фармасьютикалз, Инк. |
Способы и композиции для модулирования экспрессии аполипопротеина (а)
|
DK3461895T3
(da)
|
2012-06-25 |
2020-07-20 |
Ionis Pharmaceuticals Inc |
Modulation af ube3a-ats-ekspression
|
US20150297629A1
(en)
|
2012-07-27 |
2015-10-22 |
Isis Pharmaceuticals, Inc. |
Modulation of renin-angiotensin system (ras) related diseases by angiotensinogen
|
WO2014045126A2
(en)
|
2012-09-18 |
2014-03-27 |
Uti Limited Partnership |
Treatment of pain by inhibition of usp5 de-ubiquitinase
|
EP4052709A1
(de)
|
2012-10-11 |
2022-09-07 |
Ionis Pharmaceuticals, Inc. |
Verfahren zur behandlung der kennedy-krankheit
|
AR092982A1
(es)
|
2012-10-11 |
2015-05-13 |
Isis Pharmaceuticals Inc |
Modulacion de la expresion de receptores androgenicos
|
EP2906256B1
(de)
|
2012-10-12 |
2018-08-22 |
Ionis Pharmaceuticals, Inc. |
Selektive antisense-verbindungen und verwendungen davon
|
EP2906255B1
(de)
|
2012-10-12 |
2023-02-22 |
Ionis Pharmaceuticals, Inc. |
Antisense-verbindungen und verwendungen davon
|
EP2906696B2
(de)
|
2012-10-15 |
2022-12-14 |
Ionis Pharmaceuticals, Inc. |
Verfahren zur modulierung der c9orf72-expression
|
BR112015009559A2
(pt)
|
2012-10-31 |
2017-11-14 |
Isis Pharmaceuticals Inc |
uso de composto antissenso na preparação de medicamento para tratamento de cãncer, composto antissenso e composição farmacêutica
|
CN117126846A
(zh)
|
2012-11-15 |
2023-11-28 |
罗氏创新中心哥本哈根有限公司 |
寡核苷酸缀合物
|
KR20150088305A
(ko)
|
2012-11-26 |
2015-07-31 |
로슈 이노베이션 센터 코펜하겐 에이/에스 |
Fgfr3 발현의 조절을 위한 조성물 및 방법
|
US8968174B2
(en)
|
2013-01-16 |
2015-03-03 |
Thoratec Corporation |
Motor fault monitor for implantable blood pump
|
US9371826B2
(en)
|
2013-01-24 |
2016-06-21 |
Thoratec Corporation |
Impeller position compensation using field oriented control
|
JP6580993B2
(ja)
|
2013-01-30 |
2019-09-25 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
Lnaオリゴヌクレオチド糖質コンジュゲート
|
WO2014118272A1
(en)
|
2013-01-30 |
2014-08-07 |
Santaris Pharma A/S |
Antimir-122 oligonucleotide carbohydrate conjugates
|
CA2899924A1
(en)
|
2013-02-04 |
2014-08-07 |
Isis Pharmaceuticals, Inc. |
Selective antisense compounds and uses thereof
|
AU2014216137B2
(en)
|
2013-02-14 |
2018-05-10 |
Ionis Pharmaceuticals, Inc. |
Modulation of Apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LPLD) populations
|
US9556873B2
(en)
|
2013-02-27 |
2017-01-31 |
Tc1 Llc |
Startup sequence for centrifugal pump with levitated impeller
|
CN105143470B
(zh)
|
2013-02-28 |
2020-06-09 |
德克萨斯大学系统董事会 |
用于将癌症分类为易感于tmepai定向疗法以及治疗所述癌症的方法
|
DE102013102194A1
(de)
*
|
2013-03-06 |
2014-09-11 |
Werner Eck |
Antriebseinrichtung für ein sich in einem Fluid bewegendes Fahrzeug
|
CN111254145A
(zh)
|
2013-03-14 |
2020-06-09 |
Ionis制药公司 |
用于调节tau表达的组合物和方法
|
US10052420B2
(en)
|
2013-04-30 |
2018-08-21 |
Tc1 Llc |
Heart beat identification and pump speed synchronization
|
EP3633039A1
(de)
|
2013-05-01 |
2020-04-08 |
Ionis Pharmaceuticals, Inc. |
Zusammensetzungen und verfahren
|
JP6694382B2
(ja)
|
2013-06-21 |
2020-05-13 |
アイオーニス ファーマシューティカルズ, インコーポレーテッドIonis Pharmaceuticals,Inc. |
標的核酸を調節するための組成物および方法
|
EP3656386A1
(de)
|
2013-06-21 |
2020-05-27 |
Ionis Pharmaceuticals, Inc. |
Verbindungen und verfahren zur modulation der apolipoprotein-c-iii-expression zur verbesserung eines diabetischen profils
|
CN112263682A
(zh)
|
2013-06-27 |
2021-01-26 |
罗氏创新中心哥本哈根有限公司 |
靶向pcsk9的反义寡聚体和缀合物
|
EP3730614A3
(de)
|
2013-07-02 |
2020-12-30 |
Ionis Pharmaceuticals, Inc. |
Modulatoren des wachstumshormonrezeptors
|
TWI772856B
(zh)
|
2013-07-19 |
2022-08-01 |
美商百健Ma公司 |
用於調節τ蛋白表現之組合物
|
HUE048710T2
(hu)
|
2013-08-08 |
2020-08-28 |
Scripps Research Inst |
Eljárás nukleinsavak in vitro helyspecifikus enzimes jelölésére nem-természetes nukleotidok beépítésével
|
TW201536329A
(zh)
|
2013-08-09 |
2015-10-01 |
Isis Pharmaceuticals Inc |
用於調節失養性肌強直蛋白質激酶(dmpk)表現之化合物及方法
|
US9670492B2
(en)
|
2013-08-28 |
2017-06-06 |
Ionis Pharmaceuticals, Inc. |
Modulation of prekallikrein (PKK) expression
|
EP3043827B1
(de)
|
2013-09-13 |
2019-07-03 |
Ionis Pharmaceuticals, Inc. |
Inhibitoren des komplementfaktors b
|
US9943604B2
(en)
|
2013-09-20 |
2018-04-17 |
Ionis Pharmaceuticals, Inc. |
Targeted therapeutic nucleosides and their use
|
CN105637090B
(zh)
|
2013-10-11 |
2020-10-16 |
Ionis制药公司 |
用于调节c9orf72表达的组合物
|
US9239345B2
(en)
|
2013-11-20 |
2016-01-19 |
Woodward, Inc. |
Controlling a motor with two or more Hall sensors
|
EP3077510B1
(de)
|
2013-12-02 |
2020-05-06 |
Ionis Pharmaceuticals, Inc. |
Antisense-verbindungen und verwendungen davon
|
HUE052243T2
(hu)
|
2013-12-24 |
2021-04-28 |
Ionis Pharmaceuticals Inc |
Az angiopoietin-szerû 3 expressziójának modulációja
|
US10988030B2
(en)
|
2014-09-26 |
2021-04-27 |
Francis Xavier Gentile |
Electric motor, generator and battery combination
|
CA2942340A1
(en)
|
2014-03-19 |
2015-09-24 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating ataxin 2 expression
|
SG10201906520RA
(en)
|
2014-04-01 |
2019-09-27 |
Biogen Ma Inc |
Compositions for modulating sod-1 expression
|
WO2015157555A2
(en)
|
2014-04-09 |
2015-10-15 |
The Scripps Research Institute |
Import of unnatural or modified nucleoside triphosphates into cells via nucleic acid triphosphate transporters
|
WO2015164693A1
(en)
|
2014-04-24 |
2015-10-29 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds comprising alpha-beta-constrained nucleic acid
|
US9926556B2
(en)
|
2014-04-28 |
2018-03-27 |
Ionis Pharmaceuticals, Inc. |
Linkage modified oligomeric compounds
|
HUE052709T2
(hu)
|
2014-05-01 |
2021-05-28 |
Ionis Pharmaceuticals Inc |
Módosított antiszensz oligonukleotidok konjugátumai és azok alkalmazása PKK expressziójának módosítására
|
US10098959B2
(en)
|
2014-05-01 |
2018-10-16 |
Ionis Pharmaceuticals, Inc. |
Method for synthesis of reactive conjugate clusters
|
WO2015179693A1
(en)
|
2014-05-22 |
2015-11-26 |
Isis Pharmaceuticals, Inc. |
Conjugated antisense compounds and their use
|
US9623161B2
(en)
|
2014-08-26 |
2017-04-18 |
Tc1 Llc |
Blood pump and method of suction detection
|
WO2016077704A1
(en)
|
2014-11-14 |
2016-05-19 |
The Regents Of The University Of California |
Modulation of agpat5 expression
|
CN105634225B
(zh)
*
|
2014-11-26 |
2020-10-09 |
德昌电机(深圳)有限公司 |
直流无刷电机及使用其的电动助力转向系统
|
CA2970177C
(en)
|
2014-12-08 |
2023-09-19 |
The Board Of Regents Of The University Of Texas System |
Lipocationic polymers and uses thereof
|
CA2970795A1
(en)
|
2014-12-18 |
2016-06-23 |
Alnylam Pharmaceuticals, Inc. |
Reversir compounds
|
CN104617827B
(zh)
*
|
2015-02-02 |
2017-05-31 |
东南大学 |
一种电动汽车用轴向磁场磁通切换永磁电机容错控制方法
|
WO2016130846A1
(en)
|
2015-02-11 |
2016-08-18 |
Thoratec Corporation |
Heart beat identification and pump speed synchronization
|
US10371152B2
(en)
|
2015-02-12 |
2019-08-06 |
Tc1 Llc |
Alternating pump gaps
|
WO2016130944A1
(en)
|
2015-02-12 |
2016-08-18 |
Thoratec Corporation |
System and method for controlling the position of a levitated rotor
|
EP3626277A1
(de)
|
2015-02-13 |
2020-03-25 |
Tc1 Llc |
Laufradaufhängungsmechanismus für herzpumpe
|
MX2017011010A
(es)
|
2015-02-26 |
2017-10-20 |
Ionis Pharmaceuticals Inc |
Moduladores de rodopsina p23h con especificidad de alelo.
|
WO2016141236A1
(en)
|
2015-03-03 |
2016-09-09 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating mecp2 expression
|
WO2016141145A1
(en)
|
2015-03-03 |
2016-09-09 |
Ionis Pharmaceuticals, Inc. |
Methods for modulating mecp2 expression
|
JP2018519811A
(ja)
|
2015-06-29 |
2018-07-26 |
アイオーニス ファーマシューティカルズ, インコーポレーテッドIonis Pharmaceuticals,Inc. |
修飾crispr rna及び修飾単一crispr rnaならびにその使用
|
EP4092119A3
(de)
|
2015-07-10 |
2023-03-22 |
Ionis Pharmaceuticals, Inc. |
Modulatoren der diacyglycerol-acyltransferase (2 dgat2)
|
US11053495B2
(en)
|
2015-07-17 |
2021-07-06 |
Alnylam Pharmaceuticals, Inc. |
Multi-targeted single entity conjugates
|
CN108271360B
(zh)
|
2015-09-14 |
2023-01-24 |
得克萨斯州大学系统董事会 |
亲脂阳离子树枝状聚合物及其用途
|
AR106135A1
(es)
|
2015-09-24 |
2017-12-13 |
Ionis Pharmaceuticals Inc |
Moduladores de la expresión del sarcoma de la rata de kirsten (kras)
|
US10117983B2
(en)
|
2015-11-16 |
2018-11-06 |
Tc1 Llc |
Pressure/flow characteristic modification of a centrifugal pump in a ventricular assist device
|
WO2017106767A1
(en)
|
2015-12-18 |
2017-06-22 |
The Scripps Research Institute |
Production of unnatural nucleotides using a crispr/cas9 system
|
AU2017267634C1
(en)
|
2016-05-16 |
2022-05-26 |
The Board Of Regents Of The University Of Texas System |
Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids
|
WO2017223528A1
(en)
|
2016-06-24 |
2017-12-28 |
The Scripps Research Institute |
Novel nucleoside triphosphate transporter and uses thereof
|
US11065979B1
(en)
|
2017-04-05 |
2021-07-20 |
H55 Sa |
Aircraft monitoring system and method for electric or hybrid aircrafts
|
US10322824B1
(en)
|
2018-01-25 |
2019-06-18 |
H55 Sa |
Construction and operation of electric or hybrid aircraft
|
US11063323B2
(en)
|
2019-01-23 |
2021-07-13 |
H55 Sa |
Battery module for electrically-driven aircraft
|
US11148819B2
(en)
|
2019-01-23 |
2021-10-19 |
H55 Sa |
Battery module for electrically-driven aircraft
|
CA3071016A1
(en)
|
2017-08-03 |
2019-02-07 |
Synthorx, Inc. |
Cytokine conjugates for the treatment of autoimmune diseases
|
AR114445A1
(es)
|
2018-02-26 |
2020-09-09 |
Synthorx Inc |
Conjugados de il-15, y sus usos
|
MX2020011570A
(es)
|
2018-05-07 |
2020-11-24 |
Alnylam Pharmaceuticals Inc |
Administracion extrahepatica.
|
TW202028465A
(zh)
|
2018-09-28 |
2020-08-01 |
美商阿尼拉製藥公司 |
甲狀腺素運載蛋白(TTR)iRNA組成物及其治療或預防TTR相關眼部疾病之使用方法
|
MA54952A
(fr)
|
2019-02-06 |
2022-05-11 |
Synthorx Inc |
Conjugués d'il-2 et méthodes d'utilisation de ceux-ci
|
AR118513A1
(es)
|
2019-03-29 |
2021-10-20 |
Mitsubishi Tanabe Pharma Corp |
Compuestos para modular la expresión de dux4, métodos y composiciones farmacéuticas de estos
|
WO2020208527A1
(en)
|
2019-04-08 |
2020-10-15 |
H55 Sa |
Power supply storage and fire management in electrically-driven aircraft
|
CA3138915A1
(en)
|
2019-05-17 |
2020-11-26 |
Alnylam Pharmaceuticals, Inc. |
Oral delivery of oligonucleotides
|
MX2022001776A
(es)
|
2019-08-15 |
2022-03-17 |
Synthorx Inc |
Terapias de combinacion de inmuno oncologia con conjugados de il-2.
|
AU2020337869A1
(en)
|
2019-08-23 |
2022-03-03 |
Synthorx, Inc. |
IL-15 conjugates and uses thereof
|
CA3150082A1
(en)
|
2019-09-10 |
2021-03-18 |
Jerod PTACIN |
IL-2 CONJUGATES AND METHODS OF USE FOR TREATING AUTOIMMUNE DISEASES
|
JP2022554272A
(ja)
|
2019-11-04 |
2022-12-28 |
シンソークス, インコーポレイテッド |
インターロイキン10コンジュゲートおよびその使用
|
WO2021092145A1
(en)
|
2019-11-06 |
2021-05-14 |
Alnylam Pharmaceuticals, Inc. |
Transthyretin (ttr) irna composition and methods of use thereof for treating or preventing ttr-associated ocular diseases
|
KR20220110749A
(ko)
|
2019-11-06 |
2022-08-09 |
알닐람 파마슈티칼스 인코포레이티드 |
간외 전달
|
JPWO2021230286A1
(de)
|
2020-05-12 |
2021-11-18 |
|
|
EP4171648A1
(de)
|
2020-06-25 |
2023-05-03 |
Synthorx, Inc. |
Immunonkologische kombinationstherapie mit il-2-konjugaten und anti-egfr-antikörpern
|
US20230257745A1
(en)
|
2020-07-10 |
2023-08-17 |
Alnylam Pharmaceuticals, Inc. |
Circular siRNAs
|
WO2022076859A1
(en)
|
2020-10-09 |
2022-04-14 |
Synthorx, Inc. |
Immuno oncology therapies with il-2 conjugates
|
KR20230084203A
(ko)
|
2020-10-09 |
2023-06-12 |
신톡스, 인크. |
Il-2 접합체 및 펨브롤리주맙을 사용한 면역 종양 병용 요법
|
WO2022147223A2
(en)
|
2020-12-31 |
2022-07-07 |
Alnylam Pharmaceuticals, Inc. |
2'-modified nucleoside based oligonucleotide prodrugs
|
WO2022147214A2
(en)
|
2020-12-31 |
2022-07-07 |
Alnylam Pharmaceuticals, Inc. |
Cyclic-disulfide modified phosphate based oligonucleotide prodrugs
|
TW202302148A
(zh)
|
2021-02-12 |
2023-01-16 |
美商欣爍克斯公司 |
使用il-2接合物和抗pd-1抗體或其抗原結合片段的肺癌組合療法
|
WO2022174101A1
(en)
|
2021-02-12 |
2022-08-18 |
Synthorx, Inc. |
Skin cancer combination therapy with il-2 conjugates and cemiplimab
|
EP4314016A1
(de)
|
2021-03-31 |
2024-02-07 |
Entrada Therapeutics, Inc. |
Zyklische zellen penetrierende peptide
|
EP4337263A1
(de)
|
2021-05-10 |
2024-03-20 |
Entrada Therapeutics, Inc. |
Zusammensetzungen und verfahren zur modulation der interferon-regulatorischen faktor-5 (irf-5)-aktivität
|
CA3217463A1
(en)
|
2021-05-10 |
2022-11-17 |
Ziqing QIAN |
Compositions and methods for modulating mrna splicing
|
KR20240012425A
(ko)
|
2021-05-10 |
2024-01-29 |
엔트라다 테라퓨틱스, 인크. |
세포내 치료제를 위한 조성물 및 방법
|
US11682997B2
(en)
|
2021-05-17 |
2023-06-20 |
Hitachi Astemo Americas, Inc. |
Rotary electric machine with selectable coil control
|
TW202313117A
(zh)
|
2021-06-03 |
2023-04-01 |
美商欣爍克斯公司 |
包含il-2接合物及西妥昔單抗(cetuximab)之頭頸癌組合療法
|
WO2022271818A1
(en)
|
2021-06-23 |
2022-12-29 |
Entrada Therapeutics, Inc. |
Antisense compounds and methods for targeting cug repeats
|
WO2023283403A2
(en)
|
2021-07-09 |
2023-01-12 |
Alnylam Pharmaceuticals, Inc. |
Bis-rnai compounds for cns delivery
|
KR20240036041A
(ko)
|
2021-07-21 |
2024-03-19 |
알닐람 파마슈티칼스 인코포레이티드 |
대사 장애-연관 표적 유전자 iRNA 조성물 및 이의 사용 방법
|
IL311139A
(en)
|
2021-09-01 |
2024-04-01 |
Entrada Therapeutics Inc |
Compounds and methods for skipping exon 44 in Duchenne muscular dystrophy
|
WO2023064530A1
(en)
|
2021-10-15 |
2023-04-20 |
Alnylam Pharmaceuticals, Inc. |
Extra-hepatic delivery irna compositions and methods of use thereof
|
WO2023086295A2
(en)
|
2021-11-10 |
2023-05-19 |
University Of Rochester |
Antisense oligonucleotides for modifying protein expression
|
WO2023086292A2
(en)
|
2021-11-10 |
2023-05-19 |
University Of Rochester |
Gata4-targeted therapeutics for treatment of cardiac hypertrophy
|
WO2023122573A1
(en)
|
2021-12-20 |
2023-06-29 |
Synthorx, Inc. |
Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab
|
WO2023122750A1
(en)
|
2021-12-23 |
2023-06-29 |
Synthorx, Inc. |
Cancer combination therapy with il-2 conjugates and cetuximab
|
WO2023220744A2
(en)
|
2022-05-13 |
2023-11-16 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded loop oligonucleotides
|
WO2024006999A2
(en)
|
2022-06-30 |
2024-01-04 |
Alnylam Pharmaceuticals, Inc. |
Cyclic-disulfide modified phosphate based oligonucleotide prodrugs
|
WO2024039776A2
(en)
|
2022-08-18 |
2024-02-22 |
Alnylam Pharmaceuticals, Inc. |
Universal non-targeting sirna compositions and methods of use thereof
|
WO2024050261A1
(en)
|
2022-08-29 |
2024-03-07 |
University Of Rochester |
Antisense oligonucleotide-based anti-fibrotic therapeutics
|
WO2024073732A1
(en)
|
2022-09-30 |
2024-04-04 |
Alnylam Pharmaceuticals, Inc. |
Modified double-stranded rna agents
|